Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $808.7500 (-1.35%) ($808.7500 - $808.7500) on Tue. Apr. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 40 | Latest Price | $808.7500(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(47%) DIA(35%) VYM(33%) IWD(32%) | Factors Impacting REGN price | REGN will decline at least -0.79% in a week (0% probabilities). VXX(-29%) VIXM(-22%) UUP(-4%) TBT(-4%) SMH(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $814.7 | 5 Day Moving Average | $821.67(-1.57%) | 10 Day Moving Average | $822.31(-1.65%) | 20 Day Moving Average | $814.7(-0.73%) | To recent high | -2.6% | To recent low | 13% | Market Cap | $85.751b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |